Total expenses rose 0.89% to Rs 414.13 crore in Q1 FY26 compared with Rs 410.47 crore in Q1 FY25. Cost of material consumed stood at Rs 237.70 crore (up 1.14% YoY), employee benefit expenses was at Rs 55.23 crore (up 15.18% YoY), finance cost stood at Rs 4.03 crore (up 250.43% YoY), selling and distribution expenses stood at Rs 30.39 core (up 2.74% YoY) during the period under review.
Morepen Laboratories is a vertically integrated, innovation-led pharmaceutical and healthcare company delivering highquality APIs, branded generics, medical devices, and consumer wellness products to over 80 countries worldwide.
"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."